-
Mashup Score: 0Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers - 1 year(s) ago
This prognostic study uses data from the Swedish BioFINDER-1 and Wisconsin Registry for Alzheimer Prevention longitudinal cohort studies to evaluate whether combinations of different plasma biomarkers can predict cognitive decline in cognitively unimpaired individuals with β-amyloid positivity.
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial - 1 year(s) ago
AbstractBackground. COVID-19 convalescent plasma (CCP) reduces hospitalizations among outpatients treated early after symptom onset. It is unknown if CCP reduce
Source: OUP AcademicCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1Convalescent plasma for people with COVID‐19: a living systematic review - Iannizzi, C - 2023 | Cochrane Library - 1 year(s) ago
Collapse all Expand all Background Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and risks of this intervention is required. Objectives To assess the effectiveness and safety of…
Source: www.cochranelibrary.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Research scientists and some medical institutions have begun applying mass spectrometry (MS)–based techniques in the diagnosis and monitoring of plasma cell disorders – for example, using them to analyze measurable residual disease (MRD) in multiple myeloma (MM). Although MS-based techniques offer certain advantages, they are still relatively new, and it isn’t yet clear how these assays will best…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Physicists confirm effective wave growth theory in space - 1 year(s) ago
Physicists at Nagoya University in Japan used spacecraft data to confirm an important theory of plasma physics that improves our understanding of space weather.
Source: EurekAlert!Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Background Monoclonal antibody and antiviral treatments for COVID-19 disease remain largely unavailable worldwide, and existing monoclonal antibodies may be less active against circulating omicron variants. Although treatment with COVID-19 convalescent plasma (CCP) is promising, randomized clinical trials (RCTs) among outpatients have shown mixed results. Methods We conducted an individual…
Source: medRxivCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Johnson, Lindsey G.; Buck, Erin H.; Anastasio, Albert T.; Abar, Bijan; Fletcher, Amanda N.; Adams, Samuel B. JBJS Reviews, Year: 2022, Volume: 10, Issue: 10, DOI: 10.2106/JBJS.RVW.22.00059
Source: www.jbjs.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2
Johnson, Lindsey G.; Buck, Erin H.; Anastasio, Albert T.; Abar, Bijan; Fletcher, Amanda N.; Adams, Samuel B. JBJS Reviews, Year: 2022, Volume: 10, Issue: 10, DOI: 10.2106/JBJS.RVW.22.00059
Source: www.jbjs.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
Background COVID-19 is now a common disease, but its pathogenesis remains unknown. Blood circulating proteins reflect host defenses against COVID-19. We investigated whether evaluation of longitudinal blood proteomics for COVID-19 and merging with clinical information would allow elucidation of its pathogenesis and develop a useful clinical phenotype. Methods To achieve the first goal…
Source: SpringerLinkCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors - PubMed - 2 year(s) ago
The RRM accurately reclassifies some patients into low- and very high-risk categories, suggesting the potential to improve PN risk assessment.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
Question Can plasma biomarkers predict cognitive decline in preclinical #Alzheimer disease (AD)? Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using #Plasma #Biomarkers: #Ptau217 https://t.co/jGrIAwT6Cs via @JAMANeuro part of @JAMANetwork #amyloid #Aβ